Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Apr 11, 2019Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality ManagemeAlpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...
Jul 17, 2017Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors with Alpha RadiationFollowing the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors,...